Aggarwal, Rahul <br/><br/>
Abiraterone or Docetaxel Plus Androgen Deprivation in Hormone-Sensitive Prostate Cancer: More Questions Than Answers.  [electronic resource] 

 -  European urology  06 2018 
 - 845-846 p.  digital 
<br/><br/> Publication Type: Editorial; Comment 
<br/><br/><label>ISSN: </label>1873-7560 
<br/><br/><label>Standard No.: </label>10.1016/j.eururo.2017.10.028  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abiraterone Acetate<br/>Androgen Antagonists<br/>Androstenes<br/>Antineoplastic Combined Chemotherapy Protocols<br/>Docetaxel<br/>Humans<br/>Male<br/>Prostatic Neoplasms<br/>Prostatic Neoplasms, Castration-Resistant<br/>Taxoids